Bukwang Pharmaceutical Co., Ltd. (003000.KS)
KRW 4745.0
(-1.35%)
KRW 4745.0
(-1.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.5 Billion | 16.46 Billion | 26.52 Billion | 723.16 Million | -23.4 Billion | 6.81 Billion |
| Net Income | -31.32 Billion | -1.03 Billion | 3.78 Billion | -8.29 Billion | -1.36 Billion | 191.05 Billion |
| Depreciation & Amortization | 4.29 Billion | 5.11 Billion | 4.84 Billion | 6.15 Billion | 5.83 Billion | 6.87 Billion |
| Deferred income taxes | 15.83 Billion | - | -2.18 Billion | 8.74 Billion | -14.48 Billion | - |
| Stock-based compensation | 147.48 Million | 44.32 Million | 3.4 Million | 3.22 Billion | 348.33 Million | 323.3 Million |
| Change in working capital | 23.76 Billion | 7.15 Billion | 18.93 Billion | -9.31 Billion | -11.78 Billion | -31.69 Billion |
| Other non-cash items | -23.21 Billion | 5.17 Billion | 1.14 Billion | 206 Million | -1.96 Billion | -159.74 Billion |
| Investing Cash Flow | -2.31 Billion | -3.15 Billion | 4.74 Billion | 13.04 Billion | 18.08 Billion | 34.97 Billion |
| Investments in PPE | -2.81 Billion | -4.99 Billion | -789.52 Million | -1.95 Billion | -4.9 Billion | -3.72 Billion |
| Acquisitions | 381.08 Million | -251.26 Million | -3.03 Billion | -10 Billion | -7.1 Billion | 2 Billion |
| Investment purchases | -1.91 Billion | -1.53 Billion | -6.6 Billion | -13.83 Billion | -3.91 Billion | -3.62 Billion |
| Sales/Maturities of investments | 1.76 Billion | 3.12 Billion | 14.79 Billion | 20.62 Billion | 33.96 Billion | 40.17 Billion |
| Other Investing Activities | 267.3 Million | 502.53 Million | 388.45 Million | 18.21 Billion | 34.45 Million | 140.68 Million |
| Financing Cash Flow | 77.97 Billion | -10.39 Billion | -27.48 Billion | 28.23 Billion | -57.48 Billion | 34.46 Billion |
| Debt repayment | -80 Billion | -10 Billion | -20 Billion | -76.3 Billion | -13 Billion | - |
| Dividends payments | - | -6.84 Billion | -6.22 Billion | -12.19 Billion | -9.77 Billion | -8.61 Billion |
| Common Stock Repurchased | - | -2.74 Billion | -516.19 Million | -25.11 Billion | -50.15 Billion | -109.95 Million |
| Common Stock Issuance | - | 100 Million | - | 94.9 Billion | 12.55 Billion | 42.63 Billion |
| Other Financing Activities | 157.97 Billion | 9.09 Billion | -743.36 Million | 46.92 Billion | 2.9 Billion | 543.97 Million |
| Accounts receivables | 57.11 Billion | -1.43 Billion | 10.73 Billion | 3.99 Billion | -19.11 Billion | -25.16 Billion |
| Accounts payables | -14.16 Billion | 9.15 Billion | -2.73 Billion | -1.1 Billion | 7.05 Billion | -2.73 Billion |
| Inventory | -18.38 Billion | 208.42 Million | 12.18 Billion | -7.81 Billion | -9.91 Billion | 7.89 Billion |
| Other working capital | -806.65 Million | -772.05 Million | -1.25 Billion | -4.39 Billion | 10.18 Billion | -39.59 Billion |
| Cash at beginning of period | 85.51 Billion | 82.77 Billion | 79.29 Billion | 37.58 Billion | 100.39 Billion | 24.15 Billion |
| Cash at end of period | 151.22 Billion | 85.51 Billion | 82.77 Billion | 79.29 Billion | 37.58 Billion | 100.39 Billion |
| Capital Expenditure | -2.81 Billion | -4.99 Billion | -789.52 Million | -1.95 Billion | -4.9 Billion | -3.72 Billion |
| Effect of forex changes on cash | 552.82 Million | -172.98 Million | -303.36 Million | -297.74 Million | -11.06 Million | -7.87 Million |
| Net cash flow / Change in cash | 65.71 Billion | 2.73 Billion | 3.48 Billion | 41.7 Billion | -62.81 Billion | 76.24 Billion |
| Free Cash Flow | -13.31 Billion | 11.47 Billion | 25.73 Billion | -1.23 Billion | -28.31 Billion | 3.09 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.73 Billion | -1.91 Billion | -10.79 Billion | -31.32 Billion | -17.24 Billion | 515.99 Million |
| Depreciation & Amortization | 955.27 Million | 957.47 Million | 1.18 Billion | 4.29 Billion | 1.01 Billion | 1.06 Billion |
| Deferred income taxes | - | - | - | 15.83 Billion | - | - |
| Stock-based compensation | - | - | - | 147.48 Million | - | - |
| Change in working capital | 2.01 Billion | 12.53 Billion | 28.97 Billion | 23.76 Billion | 4.65 Billion | 4.16 Billion |
| Other non-cash items | 779.59 Million | -14.48 Billion | -2.5 Billion | -23.21 Billion | 1.94 Billion | -4.56 Billion |
| Investing Cash Flow | 10.86 Billion | -946.14 Million | 5.7 Billion | -2.31 Billion | -6.54 Billion | -514.85 Million |
| Investments in PPE | -391.94 Million | -45.5 Million | -522 Million | -2.81 Billion | -511.6 Million | -1.22 Billion |
| Acquisitions | 26.8 Million | - | 332.03 Million | 381.08 Million | 21.32 Million | -227.74 Million |
| Investment purchases | -924.8 Million | -902.64 Million | 5 Billion | -1.91 Billion | -5.95 Billion | 345.1 Million |
| Sales/Maturities of investments | 11.92 Billion | 1.99 Million | 650.5 Million | 1.76 Billion | 139.36 Million | 337.09 Million |
| Other Investing Activities | 11.25 Billion | 10.00 | 247.3 Million | 267.3 Million | -238.88 Million | 258.88 Million |
| Financing Cash Flow | -64.36 Billion | -109.52 Million | 48.26 Billion | 77.97 Billion | 29.7 Billion | -494.54 Million |
| Debt repayment | -63.34 Billion | - | -50 Billion | -80 Billion | -30 Billion | -114.64 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.01 Billion | - | 98.26 Billion | 157.97 Billion | 59.7 Billion | -379.89 Million |
| Accounts receivables | 2.03 Billion | 12.58 Billion | 26.31 Billion | 57.11 Billion | 26.9 Billion | 1.93 Billion |
| Accounts payables | 869.25 Million | -60.92 Million | -4.5 Billion | -14.16 Billion | -3.55 Billion | 295.61 Million |
| Inventory | 1.69 Billion | 4.01 Billion | 4.92 Billion | -18.38 Billion | -16.08 Billion | -409.19 Million |
| Other working capital | -1.7 Billion | -4.01 Billion | 2.23 Billion | -806.65 Million | -2.61 Billion | 2.34 Billion |
| Cash at beginning of period | 162.45 Billion | 151.22 Billion | 31.8 Billion | 85.51 Billion | 68.29 Billion | 69.79 Billion |
| Cash at end of period | 109.2 Billion | 162.45 Billion | 151.22 Billion | 151.22 Billion | 81.3 Billion | 68.29 Billion |
| Capital Expenditure | -391.94 Million | -45.5 Million | -522 Million | -2.81 Billion | -511.6 Million | -1.22 Billion |
| Effect of forex changes on cash | -771.93 Million | 568.57 Million | -914.33 Million | 552.82 Million | -507.06 Million | -1.67 Billion |
| Net cash flow / Change in cash | -53.25 Billion | 11.23 Billion | 119.41 Billion | 65.71 Billion | 13 Billion | -1.49 Billion |
| Free Cash Flow | 629.1 Million | 11.67 Billion | 16.33 Billion | -13.31 Billion | -10.15 Billion | -43.32 Million |
NLVVF
CAMLINFINE
ORCL
9341
PUODY
9052